Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-08 | New | Yet to Sell | Unknown | Equity Only | SEC link | |
| 2022-03-11 | New | $300,000 | $300,000 | Debt Only | 06b | SEC link |
| 2020-03-26 | New | $340,000 | $340,000 | Equity Only | 06b | SEC link |
| 2018-09-14 | New | $357,192 | $357,192 | Debt Only | 06b | SEC link |
| 2017-02-28 | New | $225,000 | $225,000 | Equity Only | 06b | SEC link |
| 2015-11-24 | Amended | $620,000 | $595,000 | Equity Only | 06b | SEC link |
| 2014-03-17 | New | $25,000 | $25,000 | Equity Only | 06b | SEC link |
| 2012-10-17 | New | $50,000 | $50,000 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Jeff Amerine | Director |
| Ramsay Ball | Director |
| John Coats | Executive |
| John (Jack) C. Coats | Director, Executive |
| Geoffrey Dalbow | Director |
| Robert Calvin Goforth | Director |
| R. Calvin Goforth | Director |
| Stan Green | Director |
| Stanley D. Green | Director |
| Mark Kidd | Executive |
| Omid Moghadam | Director |
| Mark Wagstaff | Executive |